Plasmonic nanoparticle-based surface-enhanced Raman spectroscopy-guided photothermal therapy: emerging cancer

Anindita Das1, Hsieh-Chih Tsai2,3,4, Tapas Sen5

  • 1Department of Physics, Nanophotonics Lab, Indian Institute of Technology (Indian School of Mines), Dhanbad, Jharkhand, 826004, India.

Insights

This review highlights plasmonic nanoparticles for cancer theranostics, combining surface-enhanced Raman spectroscopy (SERS) imaging with photothermal therapy (PTT). These minimally invasive optical techniques offer precise diagnosis and targeted treatment for improved oncological research.

Area of Science:

  • Oncological research
  • Biomedical optics
  • Nanomedicine

Background:

  • Optical imaging offers minimally invasive molecular and cellular insights into cancer.
  • Photothermal therapy (PTT) presents a highly specific and noninvasive therapeutic approach.
  • Integrating SERS imaging with PTT shows promise for cancer theranostics.

Purpose of the Study:

  • To review recent advancements in plasmonic nanoparticles for SERS-guided PTT.
  • To explore the fundamental principles of SERS and PTT in medical applications.
  • To provide an updated overview of nanoparticle development for cancer theranostics.

Main Methods:

  • Literature review of recent research on plasmonic nanoparticles.
  • Analysis of surface-enhanced Raman spectroscopy (SERS) principles.
  • Exploration of photothermal therapy (PTT) mechanisms and applications.

Main Results:

  • Plasmonic nanoparticles are crucial for developing effective SERS-guided PTT.
  • SERS provides sensitive molecular detection, while PTT enables targeted thermal ablation.
  • Combined approaches enhance diagnostic accuracy and therapeutic efficacy in cancer treatment.

Conclusions:

  • SERS-guided PTT using plasmonic nanoparticles represents a powerful strategy for cancer theranostics.
  • Further development of these nanoparticles can lead to improved minimally invasive cancer diagnosis and therapy.
  • This integrated approach holds significant potential for future oncological interventions.